Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
A. Seenipandi & P. Subramanian. (2015) Protective effect of atorvastatin on circadian regulation of liver marker enzymes and redox status in hyperlipidemic rats. Biological Rhythm Research 46:6, pages 823-832.
Read now
Read now
James J. DiNicolantonio, Carl J. Lavie, Victor L. Serebruany & James H. O'Keefe. (2013) Statin Wars: The Heavyweight Match-Atorvastatin versus Rosuvastatin for the Treatment of Atherosclerosis, Heart Failure, and Chronic Kidney Disease. Postgraduate Medicine 125:1, pages 7-16.
Read now
Read now
Carl J. Lavie, Richard V. Milani & James H. O'Keefe. (2010) Does the Choice of Statin Really Matter?. Postgraduate Medicine 122:3, pages 243-247.
Read now
Read now
Articles from other publishers (23)
Adriana Adamičková, Nikola Chomaničová, Andrea Gažová, Juraj Maďarič, Zdenko Červenák, Simona Valášková, Matúš Adamička & Jan Kyselovic. (2023) Effect of Atorvastatin on Angiogenesis-Related Genes VEGF-A, HGF and IGF-1 and the Modulation of PI3K/AKT/mTOR Transcripts in Bone-Marrow-Derived Mesenchymal Stem Cells. Current Issues in Molecular Biology 45:3, pages 2326-2337.
Crossref
Crossref
Wencui Yin, Reem I. Alwabli, Mohamed W. Attwa, A. F. M. Motiur Rahman & Adnan A. Kadi. (2022) Simvastatin: In Vitro Metabolic Profiling of a Potent Competitive HMG-CoA Reductase Inhibitor. Separations 9:12, pages 400.
Crossref
Crossref
Gang Su, Guangli Sun, Jian Lv, Weiwei Zhang, Hai Liu, Yajing Tang & Haoang Su. (2021) Hsa_circ_0004831 downregulation is partially responsible for atorvastatinalleviated human umbilical vein endothelial cell injuries induced by ox-LDL through targeting the miR-182-5p/CXCL12 axis. BMC Cardiovascular Disorders 21:1.
Crossref
Crossref
Lawrence Bai, Madeleine K D Scott, Ethan Steinberg, Laurynas Kalesinskas, Aida Habtezion, Nigam H Shah & Purvesh Khatri. (2021) Computational drug repositioning of atorvastatin for ulcerative colitis. Journal of the American Medical Informatics Association 28:11, pages 2325-2335.
Crossref
Crossref
Zhen Vin Lee & Bashir Hanif. 2018. Primary Angioplasty. Primary Angioplasty
1
13
.
Huan Ma, Yong Liu, Haixia Xie, Guolin Zhang, Huimin Zhan, Zhi Liu, Ping Wang, Qingshan Geng & Lan Guo. (2017) The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Medicine 96:32, pages e7351.
Crossref
Crossref
Yanjiao Yang, Xiaojiao Zhao, Xiao Tang, Jianxin Lu, Minjie Zhou, Wenji Wang, Lixin Wang, Daqiao Guo & Feng Ding. (2014) Comparison of Serum Cystatin C and Creatinine Level Changes for Prognosis of Patients After Peripheral Arterial Angiography. Angiology 66:8, pages 766-773.
Crossref
Crossref
Takayuki Matsuda, Ayumu Okuda, Yuichiro Watanabe, Tohru Miura, Hidefumi Ozawa, Ayako Tosaka, Koichi Yamazaki, Yuki Yamaguchi, Sayaka Kurobuchi, Minoru Koura & Kimiyuki Shibuya. (2015) Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists. Bioorganic & Medicinal Chemistry Letters 25:6, pages 1274-1278.
Crossref
Crossref
Allen Kuo & Michael Fong. 2015. Lipid Management. Lipid Management
175
185
.
Moo-Sik Lee, Andreas J. Flammer, Hyun-Soo Kim, Jee-Young Hong, Jing Li, Ryan J. Lennon & Amir Lerman. (2014) The Prevalence of Cardiovascular Disease Risk Factors and the Framingham Risk Score in Patients Undergoing Percutaneous Intervention Over the Last 17 Years by Gender: Time-trend Analysis From the Mayo Clinic PCI Registry. Journal of Preventive Medicine & Public Health 47:4, pages 216-229.
Crossref
Crossref
A. Sicras-Mainar, A. Planas-Comes, X. Frias-Garrido, R. Navarro-Artieda, M. de Salas-Cansado & J. Rejas-Gutiérrez. (2012) Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease. Journal of Clinical Pharmacy and Therapeutics 37:4, pages 441-447.
Crossref
Crossref
Michael Grabner, Wallace Johnson, Abdulla M. Abdulhalim, Andreas Kuznik & C. Daniel Mullins. (2011) The Value of Atorvastatin Over the Product Life Cycle in the United States. Clinical Therapeutics 33:10, pages 1433-1443.
Crossref
Crossref
John W. Ullrich, Robert Morris, Ronald C. Bernotas, Jeremy M. Travins, James Jetter, Rayomand Unwalla, Elaine Quinet, Ponnal Nambi, Irene Feingold, Christine Huselton, Christofer Enroth, Anna Wilhelmsson, Annika Goos-Nilsson & Jay Wrobel. (2010) Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists. Bioorganic & Medicinal Chemistry Letters 20:9, pages 2903-2907.
Crossref
Crossref
Ronald C. Bernotas, Robert R. Singhaus, David H. Kaufman, Jeremy M. Travins, John W. Ullrich, Rayomand Unwalla, Elaine Quinet, Mark Evans, Ponnal Nambi, Andrea Olland, Björn Kauppi, Anna Wilhelmsson, Annika Goos-Nilsson & Jay Wrobel. (2010) 4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists. Bioorganic & Medicinal Chemistry Letters 20:1, pages 209-212.
Crossref
Crossref
Ronald C. Bernotas, David H. Kaufman, Robert R. Singhaus, John Ullrich, Rayomand Unwalla, Elaine Quinet, Ponnal Nambi, Anna Wilhelmsson, Annika Goos-Nilsson & Jay Wrobel. (2009) 4-(3-Aryloxyaryl)quinoline alcohols are liver X receptor agonists. Bioorganic & Medicinal Chemistry 17:23, pages 8086-8092.
Crossref
Crossref
Hong Zhao, Cheng Li, Jian-Guo Cao, Hong-Lin Xiang, Hua-Zhong Yang, Ji-Liang You, Cheng-Long Li & Xiao-Hua Fu. (2009) 7-Difluoromethyl-5,4′-dimethoxygenistein, a Novel Genistein Derivative, Has Therapeutic Effects on Atherosclerosis in a Rabbit Model. Journal of Cardiovascular Pharmacology 54:5, pages 412-420.
Crossref
Crossref
James H. O'Keefe, Maia D. Carter & Carl J. Lavie. (2009) Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach. Mayo Clinic Proceedings 84:8, pages 741-757.
Crossref
Crossref
Carl J. Lavie & Mandeep R. Mehra. (2009) Statins and Advanced Heart Failure-Alive But Barely Breathing After CORONA and GISSI-HF. Congestive Heart Failure 15:4, pages 157-158.
Crossref
Crossref
Jing Ai, Xinxin Yan, Limei Zhao, Yuan Lu, Feng Liang, Benzhi Cai, Guoyu Li, Yanjie Lu & Baofeng Yang. (2009) The Protective Effect of Daming Capsule on Heart Function in Streptozocin-Induced Diabetic Rats with Hyperlipidemia. Biological and Pharmaceutical Bulletin 32:8, pages 1354-1358.
Crossref
Crossref
James H. O'Keefe, Kevin A. Bybee & Carl J. Lavie. (2008) Is Carotid Intima-Media Thickness a Reliable Clinical Predictor?–Reply–I. Mayo Clinic Proceedings 83:11, pages 1300-1301.
Crossref
Crossref
Maia Carter & James H. O'Keefe. (2008) Is Red Yeast Rice a Suitable Alternative for Statins?. Mayo Clinic Proceedings 83:11, pages 1294.
Crossref
Crossref
James H. O'Keefe, Kevin A. Bybee & Carl J. Lavie. (2008) Intensive Lipid Intervention in the Post-ENHANCE Era. Mayo Clinic Proceedings 83:8, pages 867-869.
Crossref
Crossref
James H. O'Keefe, Kevin A. Bybee & Carl J. Lavie. (2008) Intensive Lipid Intervention in the Post-ENHANCE Era. Mayo Clinic Proceedings 83:8, pages 867-869.
Crossref
Crossref